MANAGEMENT OF COMBINED ANTIVIRAL THERAPY IN PRISONERS WITH HCV INFECTIOUS DISEASE

Authors

  • Imnadze T. იმნაძე თ.
  • Vashakidze E. ვაშაკიძე ე.
  • Gegeshidze T. გეგეშიძე თ.

DOI:

https://doi.org/10.52340/csw.2016.50.0.66-68

Keywords:

No Keywords

Abstract

The aim of our study is to assess efficacy of antiviral therapy and manage side effects in patients with HCV. In study group with I genotype RVR- rapid viral response was negative in 100%; EVR- rapid response was negative in 99%; EOT- final response to treatment –was negative in 94%; SVR- permanent viral response was negative in 91%; In patients with II genotype-RVR-rapid viral response was negative  in 100%; EVR- early viral response was negative in 99%; EOT- final response to treatment was negative in 96%; SVR-permanent viral response was negative in 91%; In patients with III genotype: RVR-rapid viral response was negative  in 100%; EVR- early viral response was negative in 94%; EOT- final response to treatment was negative in 94%; SVR-permanent viral response was negative in 93%; According to our observation the final results of antiviral therapy, side effects and their management in study group do not differ from the same in another population. Although the  psychological environment is specific for study group the project is going on successfully and the obtained results prove that this project has to be continued. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Dumont DM, ALLEN SA, Brockmann BW, Alexander NE, Rich JD. Incarceration, community health and racial disparities. J. Health Cave Poor Underserved. 2013, 24:778-88.

EASL Clinical Practice Guidelines. Management of hepatitis C Virus infectios. J. Hepatology 2011, 55, 245-264.

Fazel S, Gram M, Kling B, Hawton K. Prison suicide in 12 countries: an ecological study of 861 suicide during 2003-2007. Soc psychiatry Psychiatry Epidemiol 2011; 46: 191-5. 4. Kirwan P, Evans B, Brant L. Hepatitis C and B testing in English prisioners is low but increasing. J. Public. Health (oxf) 2011; 3:197-204. 5. Ly KN, Xing I., Klevens RM at all. The increasing burden of moztality fozfality from viral hepatitis in USA. Ann Intern Med 2012, 156, 271-278. 6. Mitchell AE, Colvin HM, Ralmez Beasley R. Institute of medicine recommendation for the prevention an control of HBV and HCV Hepatology 2010, 51, 729-733. 7. United Nations 45/111 Basic principles for the treatment of prisioners, 1990. Available at: http://www.un.org. documents/ga/ves45/111.htm.Assessed 15 feb. 2013.

Downloads

Published

2021-06-18

How to Cite

იმნაძე თ. I. T., ვაშაკიძე ე. V. E., & გეგეშიძე თ. G. T. (2021). MANAGEMENT OF COMBINED ANTIVIRAL THERAPY IN PRISONERS WITH HCV INFECTIOUS DISEASE. TSMU COLLECTION OF SCIENTIFIC WORKS, 50, 66–68. https://doi.org/10.52340/csw.2016.50.0.66-68

Most read articles by the same author(s)

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.